Literature DB >> 11873569

[Does systematic evaluation of sickness certification II lead to less use of health insurance?].

Peder Rolfssøn Ringdal1, Kjell Haug, John Gunnar Maeland.   

Abstract

BACKGROUND: The increasing prevalence of disability pensioning in Norway has led to several attempts at strengthening the proactive role of the National Insurance System (NIS) in cases of long-term sick-listing. Since 1988, a special medical certificate is required after eight weeks of sick-leave. The aim of this study was to examine whether systematic evaluation of this medical certificate by NIS officers and NIS medical consultants could reduce future health insurance expenditure.
MATERIAL AND METHODS: In 1994 a randomised study using a paired design of the NIS local offices in the county of Hordaland was undertaken. All eight-week medical certificates in the intervention group (N = 2,237) were systematically reviewed, whereas standard routines were used for the control group (N = 1,764).
RESULTS: After three years, no significant differences were observed between the two groups in health insurance utilisation.
INTERPRETATION: We conclude that local NIS offices are unable to use the information in the eight-week sick notes to effectively influence future utilisation of health insurance. The reason may be that NIS offices lack the skills necessary for early intervention in long-term sick-listing.

Mesh:

Year:  2002        PMID: 11873569

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  2 in total

1.  Reducing sick leave by minimal postal intervention: a randomised, controlled intervention study.

Authors:  N Fleten; R Johnsen
Journal:  Occup Environ Med       Date:  2006-04-27       Impact factor: 4.402

2.  Reliability of sickness certificates in detecting potential sick leave reduction by modifying working conditions: a clinical epidemiology study.

Authors:  Nils Fleten; Roar Johnsen; Bente Skipenes Østrem
Journal:  BMC Public Health       Date:  2004-03-25       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.